People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BG Medicine, Inc. | — | Biotechnology | Seed | $2.5M | $22.2M | 2010 |
Pieter M. Van Der Meer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pieter M. Van Der Meer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Noubar Afeyan | 1 | 9 |
| Stephen Hall | 1 | 7 |
| Harry Wilcox | 1 | 6 |
| Stelios Papadopoulos | 1 | 4 |
| Timothy Harris | 1 | 4 |
| Michael W. Rogers | 1 | 4 |
| Harrison Bains | 1 | 2 |
| Pieter Muntendam | 1 | 2 |
| Harrison M. Bains | 1 | 1 |
| Timothy M. Harris | 1 | 1 |
| Paul Sohmer | 1 | 1 |
| Aram Adourian | 1 | 1 |
| Stephane W. Bancel | 1 | 1 |
| Stelios M. Papadopoulos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.